Endovascular Therapy for Low NIHSS Ischemic Strokes
This study will test the hypothesis that patients presenting within 8 hours of onset with
cerebral ischemia in the setting of proximal large vessel occlusions (LVO) and low baseline
NIHSS scores (0-5) will have better 90-day clinical outcomes (mRS distribution) with...
Age: 18 years - 66+
Gender: All
The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
The trial is designed to assess the safety and efficacy of using the Zoom Reperfusion System
in subjects diagnosed with acute ischemic stroke and undergoing a thrombectomy procedure
within 8 hours of last known well.
Age: 18 years - 66+
Gender: All
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group
study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV
events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke...
Age: 18 years - 66+
Gender: All
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group
study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV
events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke...
Age: 18 years - 66+
Gender: All
Randomization of Single vs Multiple Arterial Grafts
The primary hypothesis of ROMA is that in patients undergoing primary isolated non-emergent
coronary artery bypass surgery (CABG), the use of two or more arterial grafts compared to a
single arterial graft is associated with a reduction in the composite outcome of d...
Age: 18 - 70 years
Gender: All
Volumetric Integral Phase-shift Spectroscopy for Noninvasive Detection of Hemispheric Bioimpedance Asymmetry in Acute Brain Pathology
The purpose of this study is to assess the ability of the Fluids Monitor to detect
hemispheric bioimpedance asymmetry associated with acute brain pathology in patients
presenting with suspected Acute Ischemic Stroke (AIS).
Age: 18 years - 66+
Gender: All